Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- J Exp Med1
Search Results
Sort by
- BookJames F. Thornton, Jourdan A. Carboy.Contents:
Special considerations for Mohs patients / James Thornton and Jourdan Carboy
Anesthesia for reconstruction of facial Mohs defects / Jayne Coleman and Javier Marul
Mohs micrographic surgery / Sean Chen, Divya Srivastava, and Rajiv I. Nijhawan
Cellular- and tissue-based wound care / James Thornton and Jourdan Carboy
Full-thickness skin grafts / James Thornton and Jourdan Carboy
Split-thickness skin grafting / James Thornton and Jourdan Carboy
Cartilage grafts / James Thornton and Jourdan Carboy
Pedicled flaps / James Thornton and Jourdan Carboy
Local flaps / James Thornton and Jourdan Carboy
Scalp reconstruction / James Thornton and Jourdan Carboy
Forehead reconstruction / James Thornton and Jourdan Carboy
Introduction to nose and simple nasal defects / James Thornton and Jourdan Carboy
Complex nasal defects / James Thornton, Jourdan Carboy, and Nicholas T. Haddock
Nasal reconstruction based on subunits / James Thornton and Jourdan Carboy
Eyelid reconstruction / Ronald Mancini
Cheek reconstruction /
James Thornton and Jourdan Carboy
Chin reconstruction / James Thornton and Jourdan Carboy
Lip reconstruction / James Thornton and Jourdan Carboy
Ear reconstruction / James Thornton, Jourdan Carboy, and Christopher Derderian
Intraoperative complications and initial management / James Thornton and Jourdan Carboy
Management of complications in the acute healing stage / James Thornton and Jourdan Carboy
Management of complications in the late healing stage / James Thornton and Jourdan Carboy
Skin graft revisions / James Thornton and Jourdan Carboy
Local flap revisions / James Thornton and Jourdan Carboy
Pedicled flap revisions / James Thornton and Jourdan Carboy. - ArticleBotzenhardt U, Klein J, Ziff M.J Exp Med. 1978 May 01;147(5):1435-48.T-cell cytotoxicity of NZV mice was tested after in vitro sensitization against a group of H-2 identical strains (BALB/c, B10.D2, DBA/2, HW19). A highly significant and unexpected unidirectional cell-mediated lympholysis (CML) reaction by the sensitized NZB effector cells on these targets was found. After sensitization in vitro with stimulator cells of one H-2d strain, NZB effector cells (H-2d) lysed all other H-2d targets and to a lesser degree, some non-H-2d targets (C57BL/10, DBA/1, B10.Q, CBA, B10.S, A.SW). NZB targets were not lysed. Differences in the major histocompatibility region between NZB and other H-2d strains could be excluded as a possible explanation for the observed reaction of NZB (H-2d) against other H-2d strains. These results consequently represent the first description of a primary in vitro CML directed against determinants not coded for in the major histocompatibility complex. The responsible effector cells are demonstrated to be T cells. The CML of NZB against H-2 identiical targets appears best explained by a reaction against minor histocompatibility antigens. This, and the observed cross-reactions, would indicate that the cytotoxic T-cell system in NZB mice is not subjected to restrictions found in all normal mouse strains tested until now under similar conditions. It is suggested that this hyperreactivity is related to the autoimmune responsiveness of the NZB strain.